Literature DB >> 1661861

The actions of fentanyl to inhibit drug-induced emesis.

N M Barnes1, K T Bunce, R J Naylor, J A Rudd.   

Abstract

The ability of fentanyl to inhibit drug-induced emesis was investigated in the ferret. Initial studies established that morphine, in small doses (0.025-0.5 mg/kg s.c.), induced emesis in the ferret that decreased at the larger doses of 1 and 2 mg/kg (s.c.). Fentanyl (10-80 micrograms/kg s.c.) failed to induce emesis but in this dose range prevented the emesis induced by morphine (0.5 mg/kg s.c.), apomorphine (0.25 mg/kg s.c.), copper sulphate (100 mg/kg intragastric) and cisplatin (10 mg/kg i.v.). The antiemetic effects could be obtained in the absence of sedation or motor impairment. The antagonism by fentanyl of apomorphine-, copper sulphate- and cisplatin-induced emesis was inhibited by naloxone (0.1 or 0.5 mg/kg s.c.). It is concluded that fentanyl exerts a broad spectrum of actions to inhibit drug-induced emesis. An autoradiographic study of the binding of [3H]DAGO to the brainstem of the ferret indicated high densities of mu recognition sites in the area postrema, nucleus tractus solitarius, dorsal motor nucleus of the vagus, reticular medulla and other sites. The results are discussed in terms of balanced facilitatory and inhibitory opioid systems, regulating emesis and that the antiemetic actions of fentanyl reflect an important, although not necessarily an exclusive, action at mu opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1661861     DOI: 10.1016/0028-3908(91)90136-y

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  17 in total

1.  New directions in supportive care.

Authors:  Steven M Grunberg
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

Review 2.  Innovative approaches in the treatment of emesis.

Authors:  S M Grunberg
Journal:  Support Care Cancer       Date:  1997-01       Impact factor: 3.603

3.  Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.

Authors:  M Rieck; A F Schumacher-Schuh; V Altmann; S M Callegari-Jacques; C R M Rieder; M H Hutz
Journal:  Pharmacogenomics J       Date:  2016-10-25       Impact factor: 3.550

4.  Post-anesthesia vomiting: impact of isoflurane and morphine on ferrets and musk shrews.

Authors:  Charles C Horn; Kelly Meyers; Diana Pak; Allysa Nagy; Christian C Apfel; Brian A Williams
Journal:  Physiol Behav       Date:  2012-04-04

5.  The anti-emetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor.

Authors:  J W Watson; S F Gonsalves; A A Fossa; S McLean; T Seeger; S Obach; P L Andrews
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 6.  [Postoperative nausea and vomiting].

Authors:  C C Apfel; N Roewer
Journal:  Anaesthesist       Date:  2004-04       Impact factor: 1.041

7.  Is there a need to identify new anti-emetic drugs?

Authors:  Charles C Horn
Journal:  Drug Discov Today Ther Strateg       Date:  2007

Review 8.  Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting.

Authors:  Charles C Horn; William J Wallisch; Gregg E Homanics; John P Williams
Journal:  Eur J Pharmacol       Date:  2013-10-26       Impact factor: 4.432

Review 9.  Volunteer models for predicting antiemetic activity of 5-HT3-receptor antagonists.

Authors:  N A Minton
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 10.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.